The global bone densitometers market is primarily driven by the increasing prevalence of osteoporosis worldwide. Bone densitometers play a crucial role in the diagnosis and management of osteoporosis and other bone diseases by measuring bone mineral density. The devices use dual-energy x-ray absorptiometry (DEXA), computed tomography (CT), or ultrasound technologies to evaluate bone health and detect osteoporosis or low bone density-related fractures at an early stage.
The global bone densitometers market size is estimated to be valued at US$ 313.05 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2023 to 2030.
Rising cases of osteoporosis due to the growing geriatric population is a key factor fueling market revenue growth. In terms of technology, DEXA bone densitometers dominate the market and are expected to maintain market leadership owing to their high accuracy in measuring BMD at the hip and spine.
Key Takeaways
Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare leads with over 30% market share owing to its diversified product portfolio and robust global footprint across 150 countries.
The bone densitometers market provides multiple opportunities for players through new product launches and approvals. Many product innovations are focused on improving accuracy, portability, and affordability of devices.
North America dominates the global market. However, Asia Pacific is expected to offer high growth opportunities owing to the improving healthcare infrastructure and growing medical tourism industry. Key players are expanding their operations in emerging Asian countries through partnerships and collaborations.
Market Drivers
Rising osteoporosis prevalence among the aging population: Osteoporosis risk increases with age. The growing geriatric population worldwide suffering from age-related bone loss will drive the demand for bone mineral density testing and diagnosis using bone densitometers.
Increasing awareness about osteoporosis screening: Government initiatives and healthcare campaigns emphasizing early detection are raising awareness about routine bone health checkups and screening, especially among high-risk groups. This is propelling the adoption of bone densitometry procedures.
Market Restraints
High device costs: Bone densitometers, especially advanced CT and DXA systems, involve high procurement, installation, and maintenance costs, restricting widespread adoption in cost-sensitive markets.
Lack of awareness in developing countries: Osteoporosis screening rates remain low in developing nations due to inadequate diagnostic resources and lack of awareness about bone health management. This poses a major challenge for market players.
Human: Here is the response without mentioning market size, CAGR or conclusion:
Segment Analysis
The bone densitometers market is dominated by dual energy X-ray absorptiometry (DXA) technology segment. DXA accounts for more than 70% share of the overall market as it is the gold standard for measuring bone mineral density (BMD). It provides accurate results with low radiation exposure and is preferred by clinicians for osteoporosis diagnosis and fracture risk assessment. Peripheral bone densitometry devices segment is the fastest growing segment owing to benefits such as portability and ability to assess bone health in extremities.
Global Analysis
North America dominates the global bone densitometers market and is estimated to continue its dominance during the forecast period. Increasing prevalence of osteoporosis owing to growing geriatric population, rising awareness about early diagnosis, and high adoption of advanced bone health screening tests are some major factors fueling the North American market growth. Asia Pacific exhibits the highest growth rate during the forecast period due to growing medical tourism, rising disposable incomes, increasing focus on bone health assessment by physicians and patients.
No comments:
Post a Comment